您的位置: 首页 > 农业专利 > 详情页

Hepatitis C virus inhibitors
专利权人:
BRISTOL-MYERS SQUIBB COMPANY
发明人:
LOPEZ, OMAR D.,CHEN, QI,BELEMA, MAKONEN,HAMANN, LAWRENCE G.
申请号:
ES10714721
公开号:
ES2524542T3
申请日:
2010.03.29
申请国别(地区):
ES
年份:
2014
代理人:
摘要:
A compound of Formula (I): ** Formula ** or a pharmaceutically acceptable salt thereof, in which: s is 0 or 1; L is -L1-L2-, in which L1 and L2 are independently selected from: ** Formula ** with the proviso that at least one of L1 and L2 is different from ** Formula ** Y and Y- are independently oxygen (O) or NH; R1 is hydrogen or -C (O) Rx; R2 is hydrogen or -C (O) Ry; Rx and Ry are independently selected from cycloalkyl, heteroaryl, heterocyclyl, alkoxy and alkyl substituted with one or more substituents independently selected from aryl, alkenyl, cycloalkyl, heterocyclyl, heteroaryl, -OR3, -C (O) OR4, -NRaRb and -C (O) NRcRd, in which aryl and heteroaryl may be optionally substituted with one or more substituents independently selected from alkyl, haloalkyl, arylalkyl, heterocyclyl, heterocyclylalkyl, halogen, cyano, nitro, - C (O) OR4, OR5, -NRaRb , (NRaRb) alkyl and (MeO) (HO) P (O) O- and in which cycloalkyl and heterocyclyl may be optionally condensed with an aromatic ring and may be optionally substituted with one or more substituents independently selected from alkyl, hydroxyl, halogen, aryl, -NRaRb, oxo and -C (O) OR4; R3 is hydrogen, alkyl or arylalkyl; R4 is alkyl or arylalkyl; R5 is hydrogen, alkyl or arylalkyl; Ra and Rb are independently selected from hydrogen, alkyl, cycloalkyl, arylalkyl, heteroaryl, -C (O) R6, -C (O) OR7, -C (O) NRcRd and (NRcRd) alkyl, or alternatively, Ra and Rb , together with the nitrogen atom to which they are attached, form a five or six member ring or a bicyclic ring structure with bridge, wherein said five or six member ring or said bicyclic ring structure with bridge can optionally contain one or two additional heteroatoms independently selected from nitrogen, oxygen and sulfur and may contain one, two or three substituents independently selected from C1 to C6 alkyl, C1 to C4 haloalkyl, aryl, hydroxyl, C1 to C6 alkoxy, C1 to C4 haloalkoxy and halogen .Un compuesto de Fórmula (I):**Fórmula** o una de sus sales farmacéuticam
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充